Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide

NCT06497595 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Type 2 Diabetes Mellitus in Obese

Interventions

BEHAVIORAL: Wegovy (2.4 Mg Dose) + exercise & nutrition
OTHER: Wegovy (2.4 Mg Dose) + usual care

Sponsor

Sheba Medical Center

Collaborators

[object Object]